Original Article
Subject Categories: Cell Biology
Journal of Investigative Dermatology (2007) 127, 762–774. doi:10.1038/sj.jid.5700670; published online 28 December 2006
Increased ICAM-1 Expression Causes Endothelial Cell Leakiness, Cytoskeletal Reorganization and Junctional Alterations
Paul R Clark1,2, Thomas D Manes2,3, Jordan S Pober1,2,3,4 and Martin S Kluger1,2
- 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA
- 2Interdepartmental Program in Vascular Biology and Transplantation, Yale University School of Medicine, New Haven, Connecticut, USA
- 3Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
- 4Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA
Correspondence: Dr Martin S. Kluger, 295 Congress Avenue – Room 454, New Haven, Connecticut 06510, USA. E-mail: martin.kluger@yale.edu
Received 27 February 2006; Revised 6 September 2006; Accepted 2 October 2006; Published online 28 December 2006.
Abstract
Tumor necrosis factor (TNF)-induced ICAM-1 in endothelial cells (EC) promotes leukocyte adhesion. Here we report that ICAM-1 also effects EC barrier function. Control- or E-selectin-transduced human dermal microvascular EC (HDMEC) form a barrier to flux of proteins and to passage of current (measured as transendothelial electrical resistance or TEER). HDMEC transduced with ICAM-1 at levels comparable to that induced by TNF show reduced TEER, but do so without overtly changing their cell junctions, cell shape, or cytoskeleton organization. Higher levels of ICAM-1 further reduce TEER, increase F/G-actin ratios, rearrange the actin cytoskeleton to cause cell elongation, and alter junctional zona occludens 1 and vascular endothelial-cadherin staining. Transducing with ICAM-1 lacking an intracellular region also reduces TEER. TNF-induced changes in TEER and shape follow a similar time course as ICAM-1 induction; however, the fall in TEER occurs at lower TNF concentrations. Inhibiting NF-
B activation blocks ICAM-1 induction; TEER reduction, and shape change. Specific small-interfering RNA knockdown of ICAM-1 partially inhibits TNF-induced shape change. We conclude that moderately elevated ICAM-1 expression reduces EC barrier function and that expressing higher levels of ICAM-1 affects cell junctions and the cytoskeleton. Induction of ICAM-1 may contribute to but does not fully account for TNF-induced vascular leak and EC shape change.
Abbreviations:
ANOVA, analysis of variance; EC, endothelial cell; HDMEC, human dermal microvascular EC; SRI
B, mutagenized S32/36A I
B
super repressor of NF-
B; E-sel, E-selectin; ICAMbasal, ICAMmed, and ICAMhigh, HDMEC transductants expressing ICAM-1 at basal, medium, or high levels, respectively; ICAM
Cyto, HDMEC transductants expressing ICAM-1 with the cytoplasmic domain deleted; PBS, phosphate-buffered saline; siRNA, small-interfering RNA; TEER, transendothelial electrical resistance; TNF, tumor necrosis factor; VE-cadhedrin, vascular endothelial cadhedrin; ZO-1, zona occludens 1
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1 −/− miceOncogene Original Article
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell cultureNature Biotechnology Research (01 Aug 2004)
Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cellsJournal of Cerebral Blood Flow & Metabolism Original Article
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantationNature Medicine Article (01 Dec 2007)
See all 10 matches for Research


